212 related articles for article (PubMed ID: 12969317)
1. Egress: a receptor-regulated step in lymphocyte trafficking.
Rosen H; Sanna G; Alfonso C
Immunol Rev; 2003 Oct; 195():160-77. PubMed ID: 12969317
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
[TBL] [Abstract][Full Text] [Related]
4. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
Mandala S; Hajdu R; Bergstrom J; Quackenbush E; Xie J; Milligan J; Thornton R; Shei GJ; Card D; Keohane C; Rosenbach M; Hale J; Lynch CL; Rupprecht K; Parsons W; Rosen H
Science; 2002 Apr; 296(5566):346-9. PubMed ID: 11923495
[TBL] [Abstract][Full Text] [Related]
5. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.
Cyster JG; Schwab SR
Annu Rev Immunol; 2012; 30():69-94. PubMed ID: 22149932
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate.
Sanna MG; Liao J; Jo E; Alfonso C; Ahn MY; Peterson MS; Webb B; Lefebvre S; Chun J; Gray N; Rosen H
J Biol Chem; 2004 Apr; 279(14):13839-48. PubMed ID: 14732717
[TBL] [Abstract][Full Text] [Related]
8. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.
Cyster JG
Annu Rev Immunol; 2005; 23():127-59. PubMed ID: 15771568
[TBL] [Abstract][Full Text] [Related]
9. Finding a way out: lymphocyte egress from lymphoid organs.
Schwab SR; Cyster JG
Nat Immunol; 2007 Dec; 8(12):1295-301. PubMed ID: 18026082
[TBL] [Abstract][Full Text] [Related]
10. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Chiba K; Matsuyuki H; Maeda Y; Sugahara K
Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
[TBL] [Abstract][Full Text] [Related]
11. B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis.
Sinha RK; Park C; Hwang IY; Davis MD; Kehrl JH
Immunity; 2009 Mar; 30(3):434-46. PubMed ID: 19230723
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
13. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
14. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
15. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit.
Lo CG; Xu Y; Proia RL; Cyster JG
J Exp Med; 2005 Jan; 201(2):291-301. PubMed ID: 15657295
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.
Meissner A; Miro F; Jiménez-Altayó F; Jurado A; Vila E; Planas AM
Cardiovasc Res; 2017 Feb; 113(2):123-133. PubMed ID: 28082452
[TBL] [Abstract][Full Text] [Related]
17. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.
Alfonso C; McHeyzer-Williams MG; Rosen H
Eur J Immunol; 2006 Jan; 36(1):149-59. PubMed ID: 16342326
[TBL] [Abstract][Full Text] [Related]
18. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.
Halin C; Scimone ML; Bonasio R; Gauguet JM; Mempel TR; Quackenbush E; Proia RL; Mandala S; von Andrian UH
Blood; 2005 Aug; 106(4):1314-22. PubMed ID: 15870184
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation.
Thieme M; Zillikens D; Sadik CD
Exp Dermatol; 2017 Mar; 26(3):206-210. PubMed ID: 27574180
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
